PARP Inhibitors for Cancer Treatment – Part4 Oncologist Stephen Lemon continues his discussion on the use of PARP Inhibitors as a targeted therapy for the treatment of cancer. Visit to see more lectures from LemonMD. Dr. Stephen Lemon, M.P.H. is a board certified oncologist, cancer lecturer and writer, who produces cancer information videos and web related cancer education projects. He currently is the president of Oncology Associates of Omaha and works with CancerIS a Community -